Browsing by Author "Kumar, Vijay"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Publication Median Duration of Hospital Stay after Early Removal of Foley’s Catheter among Patients Undergoing Transurethral Resection of Prostate: A Descriptive Cross-sectional Study(Nepal Medical Association, 2021) Bhatta, Pashupati Nath; Raya, Akash; Yadav, Umesh Kumar; Kumar, Vijay; Shahi, Sanjeev; Singh, AmitAbstract: Introduction: Transurethral resection of the prostate requires a catheter in situ post-surgery. Early removal of catheter can reduce the length of hospital stay reducing the healthcare cost. It can also reduce the risk of infection due to prolonged catheterization. Our aim was to determine the median duration of hospital stay after early foley’s removal after transurethral resection of prostate among patients in a tertiary care hospital. Methods: A descriptive cross-sectional study was done in a tertiary care hospital from July 2019 to December 2020 and ethical clearance was obtained from the institutional review committee. Foley’s catheter were removed on the first post-operative day, who met the criteria of catheter removal. Convenience sampling was done. After foley’s removal patients were observed for spontaneous voiding. Patients with complications like hematuria, clot retention, urinary retention were recatherized. The data were expressed in mean with standard deviation, median with interquartile range and frequency and percentage as applicable using Statistical Package for the Social Sciences version 16. Results: Out of the 150 participants included in the study, the median duration of hospital stay after the early removal of foley's catheter was 3 days (interquartile range 2-4 days). A total of 20 (13.3%) patients underwent recatherization. Nine (6%) patients had to be recatheterized due to clot retention, and 11 (7.3%) were due to urinary retention. Conclusions: This study showed that the median duration of hospital stay after early removal of foley's catheter among patients undergoing transurethral resection of the prostate was similar to studies done in national/international settings.Publication Tamsulosin Versus Alfuzosin as Medical Expulsion Therapy for Distal Ureteric Calculi: An Analytical Study(Institute of Medicine, 2021) Kumar, Vijay; Bhatta, Pashupati; Yadav, Umesh; Singh, Amit; Raya, AkashABSTRACT Introduction: Urolithiasis is one of the most common urological problems. About 20% of urolithiasis accounts for ureteric calculi among which 2/3rd patients present with distal ureteric calculi. Alpha blockers are commonly used for effective treatment of ureteric calculi. The aim of this study was to compare effectiveness of Tamsulosin and Alfuzosin as medical expulsion therapy. Methods: This analytical study was carried out at National Medical College Department of Surgery,Urology Unit, Birgunj from October 2020 to March 2021. Ethical clearance (FNMC/439/075/76) was obtained from institutional review committee. Total 100 cases were included in the study who presented with distal ureteric calculi of <10 mm. The patients receiving Tamsulosin were recruited in Group T and those receiving Alfuzosin were recruited into Group A. The choice of treatment was made by the treating surgeons. Tamsulosin 0.4 mg was used for the patients in Group T and 10 mg Alfuzosin was used in Group A. Patients were followed-up weekly for 4 weeks. Stone expulsion rate, time to stone expulsion, colic episodes, emergency visit, use of analgesics and drug-related side-effects were recorded. Results: The rate of expulsion of stone in Tamsulosin group was 64% and that in Alfuzosin group was 66%. The expulsion time in Tamsulosin group was 4.28±3.49 days and that in Alfuzosin group was 5.02±4.09 days which was statistically insignificant (p=0.33). Mean episodes of colic and use of analgesics were similar in both groups. Backache was the most common side effect in both groups. Conclusion:Efficacy of both Alfuzosin 10 mg and Tamsulosin 0.4 mg as medical expulsion therapy is comparable to each other with minimum side effects of both the drugs. Keywords: Alfuzosin, medical expulsion therapy, Tamsulosin, urolithiasisPublication Utility of Transcutaneous Bilirubinometer in Tertiary Care Hospital(Nepal Paediatric Society (JNPS), 2017) Kumar, Vijay; Kahlon, Pardeep Singh; Singh, Palwinder; Singh, Kamail; Sharma, AnubhaAbstract: Introduction: Hyperbilirubinemia is one of the most vexing problems that may occur in 60% of term and 80% of preterm neonates. In order to reduce the risk of developing serious hyperbilirubinemia, it is vital to identify jaundiced infants who are in need of treatment as soon as possible. The objectives of this study were to find whether transcutaneous bilirubin (TcB) measurement correlates with total serum bilirubin (TSB) levels, measured with standard laboratory method and to analyse the effect of gestational age, birth weight and postnatal life on TcB and TSB. Material and Methods: A prospective study was conducted in the Department of Paediatrics, Government Medical College, Amritsar on 300 neonates with visible jaundice. These neonates were divided into various groups depending upon gestational age, birth weight and day of life. TcB readings were recorded at forehead and sternum and serum bilirubin level was measured within 30 minutes. Test of significance applied was unpaired T-test; mean value, p-value, standard deviation and Pearson's correlation coefficient 'r' were calculated. Results: Overall Mean value TcB at forehead was 15.32 with SD ± 2.75, mean TcB at sternum was 14.94 with SD ±2.51, mean value of TSB was 13.80 with SD ±2.15. Pearson’s correlation coefficient r was 0.895 for TcB forehead vs TSB, 0.903 for TcB sternum vs TSB and 0.966 between TcB forehead vs TcB sternum. Conclusion: TcB levels correlates well with the gold standard measurement of TSB. Gestational age, birth weight and day of life had no effect on TcB and TSB correlation. Transcutaneous bilirubinometer can thus be used to measure bilirubin level as a screening method for neonatal hyperbilirubinemia.